Board summary
Key figures
70,056
Registered population
60.6% aged 18–64
18.2%
Aged 65+
ICB 19.9% · England 17.9%
13.9%
Ethnic minority (non-White)
6.9% Asian · England 9.6%
8.8%
In IMD quintile 1
ICB 17.1% · England 21.0%
~5,492
Core20 residents (est.)
Resident basis; registered basis ~5,757 · see page 3
11,219
Hypertension register
+2.56% in 3 yrs · England +5.60%
595
SMI register
48.7% of Ashford's
1,192
COPD register
Reviews +5.35% in 3 yrs
Forecast to 2030
12,858
Hypertension patients, 2030
+1,639 on today
74.9%
QRISK ≥20% on statins, 2030
+4.45pp over 3 yrs
5.0%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Hypertension blood pressure control trails England.
Treatment to target is 60.1% against 64.0% in Ashford and 70.3% in England, after a -5.4% three-year change (England +3.6%).
SMI physical health checks fell over three years.
Psychosis alcohol recording is 69.8% (England 81.8%, three-year change -7.4 pp vs England +5.4 pp), alongside BMI at 71.5% and BP at 75.6%.
Heart failure, COPD and screening reviews outperform.
Heart failure reviews rose +69.0% over 2023 to 2025 to 79.1% (England 78.5%), with COPD reviews at 82.3% and breast screening at 76.3%.
Population, age and ethnicity
Mid Kent serves 70,056 patients with younger demographics and concentrated Asian diversity
Mid Kent PCN serves a registered population of 70,056 patients. Children aged 0–17 comprise 21.2% of the list, above Ashford (19.9%), NHS Kent and Medway ICB (20.7%), and England (19.6%). Older adults aged 65+ make up 18.2%, below Ashford (20.9%) and NHS Kent and Medway ICB (19.9%), but above England (17.9%). In Census estimates of usual residents in associated areas, Asian or Asian British residents account for 6.9% across the PCN (Ashford 5.8%, NHS Kent and Medway ICB 4.7%, England 9.6%), reaching 8.9% at New Hayesbank Surgery and 8.2% at Sydenham House Medical Centre.
Age profile
65+: ICB 19.9%, England 17.9%
Ethnicity
Older people · falls rows are Ashford local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Ashford LA) | 1,562 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 82.9% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 57.3% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Ashford LA) | 748 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Ashford LA) | 18.8 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
PCN Core20 deprivation is 8.8%, reaching 18.3% at Sydenham House Medical Centre
Mid Kent PCN's Core20 share is 8.8%, below Ashford (11.5%), NHS Kent and Medway ICB (17.1%), and England (21.0%). Weighted practice share is 8.2%, differing from the PCN figure by 0.53 pp. Deprivation spans an 18.3 pp range across practices: Sydenham House Medical Centre holds an 18.3% share (estimated 4,344 patients) and New Hayesbank Surgery holds 6.8% (estimated 1,197 patients), while Wye Surgery and Sellindge Surgery record 0.0%. Proactive outreach and inequality resources should prioritise these two concentrated practice lists.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
595
SMI register
0.84% recorded prevalence
379
Learning disability register
0.53% recorded prevalence
30
Care homes, 706 beds
In the PCN catchment
9.0%
Provide unpaid care
Ashford, Census 2021
Mid Kent PCN records 595 severe mental illness patients (48.7% of Ashford's register) and 379 learning disability patients (0.5% prevalence, England 0.6%). The PCN catchment also encompasses 30 care homes with 706 beds, alongside a 0.4% Gypsy or Irish Traveller community (England 0.1%). The substantial borough share of severe mental illness patients underscores the operational scale required for dedicated annual physical health check reviews.
Severe mental illness: physical health checks
SMI physical health checks trail England across BP recording at 75.6% (England 83.4%), BMI at 71.5% (England 82.1%), and alcohol at 69.8% (England 81.8%). Over 2023 to 2025, alcohol recording fell 7.4 pp while England rose +5.4 pp.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
11,219
Hypertension register
+2.56%
Register growth, 3 yrs
Ashford +3.83% · England +5.60%
−3.16pp
BP control, under 80
≤140/90 · −3.88pp aged 80+
+1,639
More patients by 2030
Forecast 12,858 (16.63%)
Hypertension case-finding and control
Hypertension prevalence is 15.8% (11,219 patients), below Ashford (16.0%) and NHS Kent and Medway ICB (16.2%), but above England (15.2%). Recent blood pressure recording is 81.5% (Ashford 85.0%, NHS Kent and Medway ICB 87.3%, England 90.0%). Blood pressure treatment to target is 60.1% (Ashford 64.0%, NHS Kent and Medway ICB 67.7%, England 70.3%), falling 5.4% over 2023 to 2025 while England rose +3.6%. Control is 57.7% for patients aged under 80 (England 67.8%, 3-year change -5.2% vs England +3.2%) and 70.9% for age 80 and over (England 81.2%, 3-year change -5.2% vs England +2.2%). Crude prevalence is not age-adjusted. Recording and control lag all comparators, indicating registered patients require prioritised recall and medication titration.
Lipids and statins
Lipid-lowering therapy for QRISK ≥ 20% patients is 65.0% (Ashford 60.8%, NHS Kent and Medway ICB 61.4%, England 63.6%), rising +7.3% over 2023 to 2025 (England +6.2%). Chronic kidney disease coverage is 72.8% (Ashford 69.5%, NHS Kent and Medway ICB 69.2%, England 70.3%). Uptake exceeds all comparators across both high-risk cohorts.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 109,648 | £1.90 | £1.90 | £1.86 | £208,331 |
| Cardiovascular (all), 2025 | 147,335 | £4.78 | £3.57 | £3.33 | £704,261 |
For lipid-regulating drugs in 2026, the PCN prescribed 109,648 items at £1.90 per item (Ashford £1.70, NHS Kent and Medway ICB £1.90, England £1.86). Mid Kent PCN spent £4,386 more than at England's unit cost across 109,648 items, with no difference from NHS Kent and Medway ICB's unit cost.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+8.53%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−1.90%
Asthma prevalence, PCN 3-yr % change
COPD review coverage reached 82.3% (England 76.4%, NHS Kent and Medway ICB 72.5%), rising +5.3% over 2023 to 2025 (England +2.8%). Asthma annual review coverage is 63.2% (England 65.7%), rising +8.5% over 2023 to 2025 (England +4.4%). On an asthma register of 4,264 patients, this leaves an estimated 1,568 patients without a recorded review in the last 12 months. For asthma patients aged 6-19, second-hand smoke status recording is 77.7% (England 78.8%).
Cancer register and children's immunisation
Cancer register prevalence is 4.2% (2,968 patients), above England (3.8%). In Q1 2025/26 childhood immunisation, 6-in-1 complete course at 24 months reached 94.9% (England 92.2%) and age-5 MMR dose 2 reached 91.5% (England 82.8%). MMR dose 2 is below the 95.0% target by 3.5 pp, with an MMR dose 1 to dose 2 gap at New Hayesbank Surgery of 4.1 pp (89.8% to 85.7%).
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
55.6%
Kent and Medway ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,630
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Kent and Medway ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 82.1% | 85.4% | 23% | 1,509 |
| Prostate | 54.4% | 53.2% | 37% | 1,435 |
| Lung | 29.4% | 33.8% | 21% | 1,109 |
| Bowel | 48.2% | 47.0% | 29% | 1,013 |
| Skin cancer | 87.5% | 87.8% | 23% | 562 |
Across NHS Kent and Medway ICB in 2022, 55.6% of cancers with a known stage were diagnosed at stage 1 or 2 (4,661 of 8,384 cases), in line with England (55.3%) but below the 75.0% national ambition by 19.4 pp. Only 63.6% of registered ICB cancers had a recorded stage (England 67.0%). Between 2013 and 2022, the ICB early-stage share rose +2.2 pp, leaving an ICB scale gap of 1,627 cases to reach 75.0%. ICB staging describes the wider health economy rather than PCN performance. Cervical screening reaches 69.2% across Mid Kent PCN but drops to 61.5% at Sydenham House Medical Centre, highlighting a primary care screening gap.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026, East Kent Hospitals University NHS Foundation Trust achieved 70.0% on the 62-day cancer standard (standard 85.0%), 15.0 pp below standard, trailing Maidstone and Tunbridge Wells NHS Trust (87.4%), the ICB (75.9%), and England (71.2%), while ahead of East Sussex Healthcare NHS Trust (67.0%). On the 28-day faster diagnosis standard, East Kent reached 71.3% (standard 75.0%), behind the ICB (76.8%) and England (79.3%). For diagnostics, 47.6% waited 6+ weeks for MRI and 63.0% for non-obstetric ultrasound at East Kent. Provider data reflect system pressures, not PCN performance. Acute waits underline the need for primary care safety-netting.
| Pathways within standard (%) | East Kent | East Sussex Healthcare | Maidstone and Tunbridge Wells | Kent and Medway ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 71.28 | 84.20 | 81.78 | 76.78 | 79.32 |
| 31-day treatment (96%) | 96.67 | 98.19 | 98.35 | 95.84 | 92.50 |
| 62-day referral to treatment (85%) | 70.01 | 67.04 | 87.43 | 75.93 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Kent | East Sussex Healthcare | Maidstone and Tunbridge Wells | England |
|---|---|---|---|---|
| MRI | 47.58 | 6.48 | 0.92 | 21.40 |
| CT | 37.45 | 0.48 | 0.51 | 9.92 |
| Echocardiography | 14.17 | 21.94 | 2.57 | 28.48 |
| Colonoscopy | 9.58 | 0.74 | 19.80 | 30.83 |
| Gastroscopy | 22.16 | 0.31 | 24.03 | 29.02 |
| All 15 DM01 tests | 48.38 | 5.27 | 6.42 | 23.14 |
| Community services activity | Kent residents | Kent and Medway ICB |
|---|---|---|
| Care contacts | 210,170 | 254,055 |
| Referrals | 59,360 | 68,085 |
| Patients with a contact | 60,605 | 72,060 |
Community services (residents of Kent), Jun 2026 (provisional). In June 2026, provisional community services data show that 65.8% of contacts with Ashford borough residents were for adults aged 65 and over (138,250 of 210,170 contacts). These borough resident contacts describe wider community services rather than PCN activity. High older-adult community activity indicates an operational opportunity to align community nursing with complex cancer and palliative monitoring.
Practice variation and patient experience
Practice variation and patient experience
In 2025/26, QOF overall achievement ranged from 64.6% at Sydenham House Medical Centre to 96.6% at Kingsnorth Medical Practice (England 92.5%). Vaccination and immunisation achievement spanned 43.5 pp, from 35.9% at Sydenham House Medical Centre to 79.3% at Sellindge Surgery (England 55.2%). Lower domain points at Sydenham House may reflect delivery bottlenecks rather than higher personalized care adjustments (3.3%).
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Wye Surgery | 122 | 0.0 | 70.8% | 62.8% | 89.1% |
| Kingsnorth | 108 | 1.7 | 78.2% | 68.9% | 88.2% |
| New Hayesbank | 90 | 6.8 | 48.3% | 61.0% | 84.2% |
| Sydenham House | 92 | 18.3 | 23.2% | 63.9% | 69.2% |
| Sellindge Surgery | 111 | 0.0 | 55.8% | 71.1% | 64.1% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Fourteen of 25 tracked three-year trends trail England, led by severe mental illness checks
Mid Kent PCN trails England on 14 of 25 tracked three-year trends. The widest lags are in severe mental illness physical health monitoring: alcohol recording fell 7.4 pp over 2023 to 2025 to 69.8% (England +5.4 pp to 81.8%) and BMI recording fell 5.5 pp to 71.5% (England +5.1 pp to 82.1%). Hypertension treatment to target dropped 5.4% over 2023 to 2025 to 60.1% (England +3.6% to 70.3%).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Alcohol record (psychosis)
BMI record (SMI)
Hypertension treated to target
BP control, under 80
BP control, 80+
Heart failure reviews
Breast screening (53-70)
Asthma reviews
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Ashford | Asset | PCN | Ashford |
|---|---|---|---|---|---|
| Care homes (catchment) | 30 (706 beds) | n/a | Schools (catchment) | 83 | n/a |
| Children's centres | 4 | 6 | Places of worship | 68 | 99 |
| Libraries | 2 | 4 | Food banks (VCS) | 1 | 1 |
| Day centres (VCS) | 2 | 36 | Children and young people (VCS) | 1 | 23 |
| Carers support groups (VCS) | 2 | 15 | Primary schools (LA maintained) | 22 | 24 |
| Primary academies | 10 | 18 | Special schools | 2 | 3 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Hypertension recall and titration clinics
Across 11,219 hypertension patients (15.8% prevalence), BP treatment to target is 60.1% (England 70.3%, Ashford 64.0%, ICB 67.7%), falling 5.4% over 2023 to 2025 (England +3.6%); recent BP recording is 81.5% (England 90.0%). Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 2
Combined SMI physical health checks
Across 595 SMI patients (48.7% of Ashford's register), recording trails England for alcohol at 69.8% (England 81.8%, -7.4 pp over 2023 to 2025 vs England +5.4 pp), BMI at 71.5% (England 82.1%, -5.5 pp) and BP at 75.6% (England 83.4%, -1.6 pp). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 3
Structured asthma annual review recall
Asthma review coverage is 63.2% (England 65.7%, Ashford 63.3%, ICB 60.4%), leaving an estimated 1,568 of 4,264 registered patients unreviewed in the last 12 months despite +8.5% three-year growth. Low cost, quick to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Culturally tailored access review (p2) | Asian / Asian British | Neighbourhood health framework · Core20PLUS5 approach | PCN |
| Targeted deprivation outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Standardise SMI physical health checks (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension recall and titration audit (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Targeted pre-school immunisation recall (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Targeted cervical screening recall (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Option 1 · Hypertension recall and titration clinics (p12) | Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to target | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Option 2 · Combined SMI physical health checks (p12) | Severe mental illness register · Patients with psychosis who have a current record of alcohol consumption · SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
| Option 3 · Structured asthma annual review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
